Targeted RFA 2018 Review Panel

Review Panel for Movember Translation Acceleration Grant to Validate Predictive Markers for Treatment Response and Outcome

A panel of experts will be assembled to review the applications submitted to this competition:
Bill Watson, Chair UCD School of Medicine
Conway Institute of Biomolecular and Biomedical Research
University College Dublin
Dublin, Ireland
Christopher Barbieri Weill Cornell Medicine
New York, NY, USA
Adam Dicker Jefferson Medical College of Thomas Jefferson University
Philadelphia, PA, USA
Robert Jeraj University of Wisconsin School of Medicine and Public Health
Madison, WI, USA
Glen Kristiansen University Hospital Bonn
Bonn, Germany
Lorelei Mucci Harvard T.H. Chan School of Public Health
Dana-Farber/Harvard Cancer Center
Boston, MA, USA
Joachim Weischenfeldt Biotech Research & Innovation Centre (BRIC)
University of Copenhagen
Copenhagen, Denmark
Catharine West The University of Manchester
Manchester, UK
Hayley Whitaker University College London
London, UK
John Ronald, Scientific Officer Robarts Research Institute
London, ON
Karla Williams, Scientific Officer University of British Columbia
Vancouver, BC
Thomas Flannery, Community Representative Toronto, ON
Neil Palmer, Community Representative Ottawa, ON
Additional panel members will be added as they are confirmed.

Prostate Cancer Awareness Month

Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

Click here for news archive